Hematologic Neoplasms: all 1,494 studies
Page 9 of 15. Open to participants first (438), then studies with results posted, then the rest; newest registration first within each.
- A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)Active, not recruitingNCT05347225Phase 1
- A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological MalignanciesTerminatedNCT05338346Phase 1
- Prevalence of FID and QoL in Patients with Oncological and with Haematological MalignanciesCompletedNCT05333913
- Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell TransplantationCompletedNCT05298930Not applicable
- SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.TerminatedNCT05293912Phase 1
- Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCTCompletedNCT05290545Phase 3
- TCR Alpha/Beta and CD19-deplete Haplo-HSCTWithdrawnNCT05288595Phase 2
- A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001)TerminatedNCT05284032Early Phase 1
- A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic MalignanciesWithdrawnNCT05279859Phase 1/2
- Cognitive-behavioural Intervention for Anxiety, Depression and Quality of Life Among Children Receiving Chemotherapy.CompletedNCT05270655Not applicable
- A Study to Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological MalignanciesCompletedNCT05269940Phase 1/2
- Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate MofetilActive, not recruitingNCT05256537Phase 2
- Clinical Study of CLL1 CAR-T Cells in the Treatment of Hematological MalignanciesStatus unknownNCT05252572Early Phase 1
- The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)Active, not recruitingNCT05250037
- Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological MalignanciesStatus unknownNCT05239689Early Phase 1
- Survivorship Post-HCT Optimization ProgramCompletedNCT05238376Not applicable
- Emotion and Symptom-focused Engagement for Caregivers (EASE-CG) Pilot StudyCompletedNCT05236296Not applicable
- Sexual Health in Patients With Hematologic MalignanciesActive, not recruitingNCT05222282Not applicable
- Managed Access Programs for PKC412, MidostaurinNo longer availableNCT05219266
- CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ LymphomaStatus unknownNCT05212584Phase 1
- A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer.WithdrawnNCT05205252Phase 1/2
- Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignanciesStatus unknownNCT05203809
- Remote Temperature Data for Early Detection of Febrile NeutropeniaCompletedNCT05180838
- Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDSStatus unknownNCT05175508Phase 2/3
- A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation TherapyActive, not recruitingNCT05173961Not applicable
- PA3-17 Injection Treatment of Adult Patients With CD7-positive Relapsed/Refractory Lymphoid Hematologic MalignanciesStatus unknownNCT05170568Phase 1
- Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy RecipientsCompletedNCT05164016
- Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD ProphylaxisStatus unknownNCT05158608Phase 3
- Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic MalignancyStatus unknownNCT05154474
- A Multicomponent Technology Supported Care Delivery for Older Patients With Hematologic Malignancies (The M-Tech Study)WithdrawnNCT05153447Not applicable
- Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer SurvivorsActive, not recruitingNCT05138991Not applicable
- Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung CancerCompletedNCT05106374
- A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic MalignancyActive, not recruitingNCT05104775Phase 1
- Impact of Donor-recipient ABO Matching on Haploidentical Stem Cell TransplantationCompletedNCT05103995
- Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 PandemicActive, not recruitingNCT05102656Not applicable
- Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological MalignancyCompletedNCT05101759Not applicable
- Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer PatientsTerminatedNCT05101213Phase 1
- Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care UnitSuspendedNCT05091632
- Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCTStatus unknownNCT05084027Phase 2
- Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors of Childhood CancerActive, not recruitingNCT05075759Not applicable
- CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology PatientsWithdrawnNCT05061654Phase 4
- Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced CancerCompletedNCT05058339
- Parental Attitudes and Beliefs Regarding Risks Associated With Opioid Use in Children With CancerActive, not recruitingNCT05055011
- Impact of Aminoglycosides in Hypotensive Septic Oncology PatientsCompletedNCT05045963
- Using of Virtual Reality to Relieve Procedural Pain in Pediatric Oncology.CompletedNCT05042479Not applicable
- Single Session of 30-Minute Mindful Breathing in Reducing FatigueCompletedNCT05029024Not applicable
- A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic MalignanciesStatus unknownNCT05028478Phase 1/2
- The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood CancerActive, not recruitingNCT05023993Not applicable
- A Study of TQB3820 in Patients With Hematological MalignanciesStatus unknownNCT05020639Phase 1
- Remote Monitoring in Cancer Care: A Platform StudyCompletedNCT05018208
- UCAR-T for CD19+ Refractory/Relapsed B Hematologic MalignanciesWithdrawnNCT05015972Early Phase 1
- Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPETerminatedNCT05012124Not applicable
- Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic MalignancyCompletedNCT05009719Phase 1/2
- Cancer Rehab Program for Allogenic Bone and Marrow Transplant Patients - CaRE-4-alloBMTCompletedNCT04966156Not applicable
- Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their SpousesActive, not recruitingNCT04960787Not applicable
- A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative NeoplasmsWithdrawnNCT04955938Phase 1
- Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy AdultsCompletedNCT04952766Phase 4
- Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)Status unknownNCT04951323Phase 3
- GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid TumorCompletedNCT04944888Phase 1
- Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy ParticipantsCompletedNCT04944771Phase 1
- Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer PatientsActive, not recruitingNCT04939090Phase 3
- Use of nMoABs for the Treatment of COVID-19 in Patients With HM.CompletedNCT04932967
- Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML)CompletedNCT04926285Phase 1
- A Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell TransplantationActive, not recruitingNCT04914338Not applicable
- The Leukemia and Lymphoma Society (LLS) T-cells in Blood Cancer and COVID-19SuspendedNCT04898985
- IIT2020-20-SHIRAZIP-WALK: Nature WalksCompletedNCT04896580Not applicable
- A Study of LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid LeukemiaWithdrawnNCT04896112Phase 1
- Distracting Through Procedural Pain and DistressCompletedNCT04892160Not applicable
- Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric PopulationCompletedNCT04889937
- Testing the Effects of Exercise on Chemotherapy-Induced Peripheral NeuropathyActive, not recruitingNCT04888988Not applicable
- Symptom Clusters in Hong Kong Chinese Children With Blood CancerStatus unknownNCT04888195
- A Study of DT2216 in Relapsed/Refractory MalignanciesCompletedNCT04886622Phase 1
- Systematic Symptom Identification With Disease Specific PROM to Assess Symptoms of Chronic GVHD in Outpatient Care in Patients Post HSCTCompletedNCT04884204Not applicable
- Immunogenicity of Covid-19 Vaccination for Patients With Hematological MalignanciesStatus unknownNCT04878822
- Patient Reported Symptom Control With THC or CBD UseActive, not recruitingNCT04875286
- Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed IndividualsStatus unknownNCT04871165
- Phase 1 Trial of the TQB2928 Injection in Patients With Advanced CancersStatus unknownNCT04854681Phase 1
- Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology PatientsCompletedNCT04852796
- Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer TreatmentActive, not recruitingNCT04829539Phase 3
- Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in OncohematologyCompletedNCT04826458Not applicable
- TORQUETENOVIRUS IN CAR-T THERAPY: PREDICTION OF THE CRSStatus unknownNCT04822974Not applicable
- VR for Symptom Control and WellbeingCompletedNCT04821466Not applicable
- Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their CaregiversCompletedNCT04810052Not applicable
- Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological MalignanciesStatus unknownNCT04796688Phase 1
- A Study Evaluating the Safety, Tolerability and Preliminary Efficacy of IBI322 in Subjects With Hematologic MalignancyCompletedNCT04795128Phase 1
- Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary LesionsStatus unknownNCT04790747Phase 1/2
- Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic MalignanciesStatus unknownNCT04767308Early Phase 1
- Body Composition and Nutritional Status in Pediatric Patients With Hematological MalignanciesCompletedNCT04764695Not applicable
- Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in SwedenCompletedNCT04760184
- Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncologyStatus unknownNCT04758442Not applicable
- Symptom Identification and Management in Patients With Hematological Malignancy During Follow-up CareCompletedNCT04757545Not applicable
- Effects of NMES and Exercise in Hematological CancerCompletedNCT04755465Not applicable
- Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic MalignanciesCompletedNCT04748185
- Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis SyndromeCompletedNCT04745910Phase 4
- Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic MalignancyStatus unknownNCT04743544
- Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health OutcomesActive, not recruitingNCT04743466
- Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune SystemStatus unknownNCT04743388
- Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological TumorsStatus unknownNCT04738955Phase 4
- Central Nervous System Disorders Following Hematopoietic Stem Cell TransplantationCompletedNCT04737785
- Project Affinity: Excess Cancer Blood TestingCompletedNCT04724005